LATINABA is a leading Contract Research Organization (CRO) providing clinical research and regulatory services across Latin America. With extensive experience in the region, we support pharmaceutical, biotechnology and medical device companies throughout the clinical development process — from regulatory strategy and study start-up to clinical operations, project management, oversight and quality. Our strength is our deep understanding of the Latin American clinical research environment. We combine regional expertise, experienced local teams and strong investigator and site relationships to help sponsors navigate regulatory requirements, operational complexities and market-specific challenges. Our services include Clinical Operations & Project Management, Regulatory Affairs, Consulting, Medical Device Research, Real World Evidence, MSL Services, Clinical Trial Oversight, Resourcing, CRO & Sponsor Oversight, and Quality Programs & Dedicated Services. LATINABA has particular experience across oncology, infectious diseases, cardiovascular, CNS, ophthalmology, vaccines, rare diseases and other complex indications, including studies involving pediatric and perinatal populations, gene therapies and medical devices. Our mission is simple: to make clinical development in Latin America more accessible, efficient and successful. LATINABA — Your CRO in Latin America.
Looking for a particular LATINABA employee's phone or email?
The LATINABA annual revenue was $3 million in 2026.
Mariano Zarzecki is the CEO of LATINABA.
20 people are employed at LATINABA.
LATINABA is based in Coral Gables, Florida.
The NAICS codes for LATINABA are [32541, 32, 3254, 325].
The SIC codes for LATINABA are [28, 283].